The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 227-234

Bentham Science Publishers

Access to resources Recommend Favorite

Innovations therapy: mammalian target of rapamycin (mTOR) inhibitors for the treatment of neuroendocrine tumors

By Capdevila Jaume   Salazar Ramón   Halperín Irene   Abad Albert   Yao James  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 27-34

Springer Publishing Company

Access to resources Recommend Favorite

Mammalian target of rapamycin as a target in hematological malignancies

By Kelly Kevin  

Targeted Oncology, Vol. 6, Iss. 1, 2011-03 ,pp. : 53-61

Springer Publishing Company

Access to resources Recommend Favorite

Expression of mammalian target of rapamycin in atherosclerotic plaques is decreased under diabetic conditions: A mechanism for rapamycin resistance

By              

Molecular Medicine Reports, Vol. 9, Iss. 6, 2014-01 ,pp. : 2388-2392

Spandidos Publications

Access to resources Recommend Favorite

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells

By                

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 575-581

Spandidos Publications

Access to resources Recommend Favorite